Earnings Call · Q2 FY2021·2021-07-21

Q2 21EPS +8.77%·Rev n/aQ1 21EPS +10.21%·Rev n/aQ4 20EPS +1.64%·Rev n/aQ3 20EPS +11.11%·Rev n/a⚠ consensus missing

JOHNSON & JOHNSON JNJ

Chris DelOrefice — Vice President of Investor Relations

Joseph Wolk — Executive Vice President, Chief Financial Officer

Jennifer Taubert — Executive Vice President, Worldwide Chairman, Pharmaceuticals

Thibaut Mongon — Executive Vice President, Worldwide Chairman, Consumer Health

Ashley McEvoy — Executive Vice President, Worldwide Chairman, Medical Devices

+0.6%1d on move date−0.2% vs SPY3d+2.0%5d+2.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more JNJ calls or request research access.

More JNJ calls Browse calls Request research access